×

Category: Op-Ed

Peter Lidsky Op-Ed
What is aging? Sadly, we don’t know. If we ask the experts in the field, they will give us different answers [1]. Consensus has not been reached on even the trivial definition of aging, let alone its primary mechanisms. But, can we cure aging without understanding it? I think not. Knowledge is essential to target...
Peter Fedichev Op-Ed
For most of the history of human civilization, humanity expanded at an astonishing pace: faster than exponential, nearly hyperbolic. This trend was famously described in a 1960 paper by Heinz von Foerster and colleagues, who extrapolated global population data to predict a so-called "Doomsday", a demographic singularity in which human numbers would become infinite by...
Mitchell Lee Ora Op-Ed
No other human endeavor today holds more promise than understanding and targeting aging. The molecular mechanisms that drive aging impact overall vigor, environmental stress resistance, reproductive health, and broad disease risk, and they fundamentally change what life means by radically changing our relationship to death. Intriguingly, aging mechanisms are highly evolutionarily conserved, so much so...
S. Jay Olshansky Op-Ed
How long can people live? This is not just a foundational question in science. The answer has important public policy implications and is of interest to us all. Recent scientific evidence has revealed the answer, so what’s next in humanity’s never-ending battle against disease and the persistent ravages of aging? Larger increases in lifespan not...
Trying to find a single cause of aging is like blinedfolded people trying to work out something is an elephant.
In the Proceedings of the National Academy of Science, Dr. Jesse Poganik and Prof. Vadim Gladyshev of Harvard Medical School have presented an opinion proposing a consensus understanding of aging. A problem of focus and funding The authors lament a lack of focus and funding in the field of gerontology, noting that a full 60%...
Joppe Nieuwenhuis
Joppe Nieuwenhuis, Innovation Scout at Rejuveron Life Sciences, discusses his views about the future of longevity and rejuvenation research and how it will merge with current medical frameworks and systems. About Rejuveron Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding...

Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.

© 2025 Lifespan Research Institute – ALL RIGHTS RESERVED